Current Clinical Trials


Currently Enrolling


A Two-Year Prospective Longitudinal Study using Quantitative and Qualitative Assessments to Define the Natural History of Gastrointestinal Symptoms in Patients with Parkinson’s Disease or at Risk for Developing the Motor Symptoms of Parkinson’s Disease.  To find our more, choose one of the following for the flyer.

 If you have Parkinson's Disease, Click Here
If you are a Family Member or have a Genetic Risk factor, Click Here  
If you have REM Sleep Behavior Disorder (RBD), Click Here 


A clinical study of patients with symptomatic neurogenic orthostatic hypotension to assess sustained effects of droxidopa therapy. Click here for flyer


A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients with Parkinson’s Disease Experiencing End-of-Dose “Wearing-Off” (TOZ-PS).
  Click here for flyer


The Parkinson’s Progression Markers Initiative.   Click here for flyer


National Parkinson Foundation Quality Improvement Initiative


Let us know if  you or someone you know is interested in participating in one of the Actively Recruiting Clinical Trials:


Not Actively Recruiting
Proteomics, Metabolomics, Lipidomics and Genetic Analysis for Biomarker DISCOVERY in Parkinson’s Disease 

Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia (EASE LID 3)



A Phase 3, Randomized Study Investigating the Safety of CVT-301 (Levodopa Inhalation Powder) in Parkinson’s Disease Patients With Motor Response Fluctuations (OFF Phenomena) Compared to an Observational Cohort Control

2500 Hospital Drive, Bldg #10, Suite 1 | Mountain View, CA 94040
650.770.0201 main | 650.770.0204 fax (Clinic Secure)